Wang, Chun-Hsiang <br/><br/>
Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period: A prospective randomized cohort study.  [electronic resource] 

 -  Medicine  May 2020 
 - e19907 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1536-5964 
<br/><br/><label>Standard No.: </label>10.1097/MD.0000000000019907  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Antiviral Agents--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--drug effects<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recurrence<br/>Seroconversion--drug effects<br/>Sustained Virologic Response<br/>Tenofovir--administration & dosage<br/>Time Factors